Bay 59-3074 is primarily used in research settings to study its potential therapeutic effects, particularly in the field of pain management and neurological disorders. It acts as a cannabinoid receptor agonist, making it valuable for investigating the endocannabinoid system and its role in modulating pain, inflammation, and neuroprotection. Researchers utilize this compound to explore its efficacy in alleviating chronic pain, neuropathic pain, and conditions like multiple sclerosis or spinal cord injuries. Additionally, it serves as a tool to understand the pharmacological mechanisms of cannabinoid receptors and their interactions with other signaling pathways. Its application is largely confined to preclinical studies, contributing to the development of novel cannabinoid-based therapies.